Zoetis™ Celebrates Initial Public Offering and First Day of Trading on the New York Stock Exchange
February 01 2013 - 12:09PM
Business Wire
Zoetis, a leading animal health company, opened for trading
today on the New York Stock Exchange (NYSE) under the ticker symbol
“ZTS” after its initial public offering. Barclays is the
Designated Market Maker (DMM) for the company’s stock. CEO Juan
Ramón Alaix, joined by members of the Zoetis team, celebrated the
company’s first day of trading by visiting the NYSE trading floor
for the stock opening and by ringing The Opening Bell.
Zoetis Chief Executive Officer Juan Ramon
Alaix, joined by members of the Zoetis team, rings the NYSE Opening
Bell to celebrate the company's IPO and first day of trading on the
NYSE. (Source: NYSE Euronext Photo)
"We welcome Zoetis to our growing community of listed
companies,” said Scott Cutler, Executive Vice President, Head of
Global Listings, NYSE Euronext. “As the largest standalone company
in animal health, Zoetis supports veterinarians and livestock
producers around the world with innovative medicines and vaccines
that help them raise and care for animals. We congratulate Zoetis
as they embark upon this new chapter and look forward to a
long-standing partnership with the company and its
shareholders.”
For more information on NYSE Euronext’s Listings business and to
learn about trends in the IPO market, please visit the NYSE
Euronext IPO Center.
About Zoetis (NYSE: ZTS)
Zoetis (zō-EH-tis) is the leading animal health company,
dedicated to supporting its customers and their businesses.
Building on a 60-year history as the animal health business of
Pfizer, Zoetis discovers, develops, manufactures and markets
veterinary vaccines and medicines, with a focus on both farm and
companion animals. The company generated annual revenue of $4.2
billion in fiscal 2011. Zoetis has more than 9,500 employees and a
local presence in approximately 70 countries, including 29
manufacturing facilities in 11 countries. Its products serve
veterinarians, livestock producers and people who raise and care
for farm and companion animals in 120 countries. (Source:
Zoetis)
About NYSE Euronext
NYSE Euronext (NYX) is a leading global operator of financial
markets and provider of innovative trading technologies. The
company's exchanges in Europe and the United States trade equities,
futures, options, fixed-income and exchange-traded products. With
approximately 8,000 listed issues (excluding European Structured
Products), NYSE Euronext's equities markets - the New York Stock
Exchange, NYSE Euronext, NYSE MKT, NYSE Alternext and NYSE Arca -
represent one-third of the world’s equities trading, the most
liquidity of any global exchange group. NYSE Euronext also operates
NYSE Liffe, one of the leading European derivatives businesses and
the world's second-largest derivatives business by value of
trading. The company offers comprehensive commercial technology,
connectivity and market data products and services through NYSE
Technologies. NYSE Euronext is in the S&P 500 index. For more
information, please visit: http://www.nyx.com.
Photos/Multimedia Gallery Available:
http://www.businesswire.com/multimedia/home/20130201005638/en/
Zoetis (NYSE:ZTS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Zoetis (NYSE:ZTS)
Historical Stock Chart
From Jul 2023 to Jul 2024